Does the Sara Combilizer®, an Early Mobilization Aid, Reduce the Time Taken to First Mobilise Ventilated Patients in Intensive Care?
NCT ID: NCT03143777
Last Updated: 2017-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
80 participants
INTERVENTIONAL
2014-04-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Invasively Ventilated Adults With Early Activity and Mobilisation
NCT03133377
Impact of the Assisted Ventilation Mode on Diaphragm Efficiency in Critically Ill Patients
NCT02473172
Ultra Protective Ventilation During Venoarterial Extracorporeal Membrane Oxygenation (UPV-ECMO)
NCT03041428
Strategy of UltraProtective Lung Ventilation With Extracorporeal CO2 Removal for New-Onset Moderate to seVere ARDS
NCT02282657
A Comparative Study of Support Devices for Ventilator-Assisted ICU Patients
NCT05996055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Sara Combilizer is a combined tilt table and stretcher chair, which allows passive transfer of patients out of bed. It is theorized the passive and safe nature of transfer may facilitate earlier mobilisation of patients within critical care. This study aimed to assess whether the introduction of the Sara Combilizer reduced time taken to first mobilize for patients mechanically ventilated for at least 5 days and at risk of ICU acquired weakness.
Patients admitted to a large UK critical care unit during the trial period and ventilated for ≥ 5 days were included in the study. Baseline data was collected prospectively for a period of 4 months. The Sara Combilizer was then introduced for a 1 month training and familiarization period, followed by a further 4 months prospective data collection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Baseline
Standard physiotherapy and mobilisation
No interventions assigned to this group
Sara Combilizer group
Ongoing care with the sara combilizer available for use
Sara Combilizer
Combined tilt table and stretcher chair
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sara Combilizer
Combined tilt table and stretcher chair
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Poor prior level of mobility (\<10yards)
* Neuromuscular disease (e.g. Guillain Barre or Motor Neurone Disease)
* Mechanical ventilation \> 48 hours at another facility prior to admission
* Expected withdrawal of treatment within 24 next hours
* Patients who have already commenced mobilisation in the 1st 5 days of admission
* Obese patients who exceed the weight limit of the product (200 kg)
* Patients over 6ft5 due to restrictions of the product
* Severe neurological injury
* Lower limb amputations
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Birmingham NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David McWilliams
Clinical Specialist Physiotherapist
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UBirminghamNHS1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.